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Abstract
This paper describes a histochemical study of superoxide generation in buffer-perfused, isolated
rat hearts during the first 2 minutes of reperfusion after 60 minutes of warm ischemia.
Superoxide radical production was demonstrated by a modification of Karnovsky's
manganese/diaminobenzidine technique, in which superoxide oxidizes Mn++ to Mn+++ ions,
which in turn oxidize diaminobenzidine to form amber, osmiophilic polymers, observable by
light or electron microscopy. Isolated hearts were rendered ischemic, reperfused with oxygen
equilibrated buffer containing Mn++ and diaminobenzidine, fixed by perfusion with Trump's
solution, and processed for light and electron microscopy. The method consistently demonstrated
evidence of superoxide generation near the luminal surfaces of arterial, capillary, and venular
endothelial cells during the first 2 minutes of reoxygenation after ischemia. The histochemical
reaction was absent or markedly reduced in non-manganese-treated or nonischemic hearts, as
well as in hearts perfused with calcium-free or oxygen-free buffers. The histochemical
differences were statistically significant on quantitative morphometric analysis. These results
provide direct, visual evidence of the existence and endothelial localization of a burst of
superoxide radicals in intact, post-ischemic myocardium and suggest the pathophysiologic
importance of calcium-dependent endothelial cell activation in the initiation of reperfusion
injury.

Supported by Grants HL-36712 and HL-35996 from the National Heart, Lung, and Blood Institute, U.S. Public
Health Service, Bethesda, Maryland, and by a Focused Giving Grant from Johnson & Johnson.
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Introduction
The clinical significance, underlying mechanisms, and indeed the very existence of reperfusion
injury in cardiac tissue have been much discussed and debated [1-9] since the initial description
by Hearse et al. [10] in 1973 of oxygen dependent enzyme release from previously ischemic rat
hearts. The potential of the myocardium to sustain a form of oxygen-mediated injury on
reperfusion, which amplifies primary hypoxic injury during ischemia, has been referred to as the
"oxygen paradox" [11, 12]: namely, that although the reintroduction of oxygen to ischemic tissue
is obviously necessary to restore normal function, post-ischemic tissues may simultaneously
suffer from a form of oxygen toxicity that is thought to be caused by oxygen centered free
radicals [2, 13-19]. Free radicals such as superoxide and the hydroxyl radical,, (O 2*) and HO*,
are extremely reactive chemical species that contain an unpaired electron in an outer orbital,
represented herein by the symbol *. The primary and most abundant free radical thought to be
formed during reperfusion is superoxide, (O2*), which is subsequently converted to other
partially reduced, reactive oxygen species: hydrogen peroxide (H2O2) and the highly toxic
hydroxyl radical (HO*) by way of the superoxide-driven Fenton reaction [13, 14, 20]. Superoxide
radicals may be generated in post-ischemic tissues by the reduced form of nicotinamide-adenine
dinucleotide phosphate oxidase in activated leukocytes [21], by nicotinamide-adenine
dinucleotide (reduced form) dehydrogenase within mitochondria [22, 23], or possibly by the
action of xanthine oxidase on xanthine and hypoxanthine substrates that accumulate during
ischemia [2, 24-26]. The sudden rise in oxygen tension during reperfusion, perhaps especially if
oxygen therapy is given, has been proposed to drive these enzymatic sources to generate a burst
of (O2* ) radicals that exceeds the scavenging capacity of antioxidant defense systems, which
may be weakened during ischemia [27].
Ischemia-reoxygenation injury of heart, in particular, has been rather intensively investigated [4,
28-33]. In most studies, the evidence that superoxide radicals actually occur in vivo is largely
indirect. Treatments such as allopurinol to block superoxide production by xanthine oxidase, or
superoxide dismutase to destroy superoxide ions, are given, and improved survival or function of
treated animals is observed. Recently, however, electron spin resonance (ESR) techniques have
been employed to provide spectroscopic evidence of a burst of free radical generation within
moments of reperfusion of previously ischemic hearts [34-37]. These methods are nonetheless
limited in that they cannot distinguish for certain the particular free radical species generated,
and they cannot show which cell types within the heart are sources of free radicals.
Seeking a more visual and direct demonstration of the elusive oxygen radicals in tissues during
the reperfusion phase, we explored a number of histochemical approaches in experimental
models that would demonstrate not only the presence of oxygen radicals but also the sites of their
formation. After testing a variety of previously published and novel routes to the deposition of a
satisfactory histochemical reaction product in the presence of either superoxide, hydrogen
peroxide, organic hydroperoxides, or the hydroxyl radical, we finally obtained excellent results
with a relatively simple modification of Karnovsky's manganese/diaminobenzidine technique
[38], previously employed to demonstrate superoxide generation by leukocytes.
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The principle of Karnovsky's method is as follows. Living cells that produce superoxide are
exposed to a physiologic solution containing added divalent manganese and diaminobenzidine
(DAB). Then
(O2*) + Mn++ + 2H+  H2O2 + Mn+++
Mn+++ + DAB  osmiophilic polymer
Nascent superoxide, which can act as either an oxidant or a reductant [39], in the present case
rapidly oxidizes divalent manganese (k = 6 x 10 6 M-1 sec-1) [40] to the trivalent state in the
presence of proton donors, with concomitant generation of hydrogen peroxide [21]. The Mn+++
ion, in turn, is able to oxidize diaminobenzidine to form an amber, osmiophilic polymer, widely
exploited as a sensitive histochemical marker [41,42]. The accumulation of polymeric reaction
product in vital tissue in the presence of Mn++ and DAB is a measure of the time integral of
(O2*) generation. This histochemical reaction for (O2 *) has now been shown to be inhibited by
the addition of exogenous superoxide dismutase to preparations of neutrophils [38] and rat
pulmonary vascular endothelium [43], thus strongly implicating its specificity for superoxide in
vivo. Mn++ is not oxidized by hydrogen peroxide, as may be readily demonstrated in simple test
tube experiments.
In optimizing the original manganese/diaminobenzidine histochemical method [38] for use in
myocardium, we realized that higher manganese concentrations might be required for efficient
trapping of superoxide in intact tissues containing superoxide dismutase (SOD). The rationale is
based on the fundamental competition between the introduced manganese and native SOD for
reaction with H2O 2:
(O2*) + Mn++ + 2H+  H2O2 + Mn+++
(k1 = 6 x 106 M-1 sec-1)
(O2*) + SOD  H2O2 + ½ O2 + SOD
(k2 = 109 M-1 sec-1).
Because the pseudo-first-order rate constant for the latter reaction is so large, the proportion of
nascent superoxide scavenged by Mn++, namely

may be substantially less than unity.
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Taking published values for rate constants k 1 and k2 [40, 44] and estimated tissue SOD at 10-6 to
10-5 mol/L [45], the scavenging efficiency of divalent manganese, p, would be approximately
9%, 50%, and 91%, respectively, for 1, 10, and 100 mmol/L (millimolar) Mn++.
Accordingly, we adopted the use of higher manganese concentrations than the 0.5 mmol/L
originally described for studies of leukocytes and found the most clear and satisfactory results
with 40 mmol/L manganese. We refer to this modification as the high manganese /
diaminobenzidine method. In the present report, we describe application of the high
manganese/diaminobenzidine method to explore superoxide radical production during
reoxygenation of previously ischemic hearts at sites that can be visualized by both light and
electron microscopy. The results show, with remarkable sharpness and clarity, the appearance of
superoxide radicals on the luminal face of vascular endothelium in post-ischemic arterioles,
capillaries, and venules of the isolated rat heart.
Materials and Methods
Chemicals
Reagent grade calcium chloride, manganese chloride, potassium chloride, sodium azide, sodium
chloride, sodium phosphate, and 37% formaldehyde stock solution were obtained from standard
sources. Glutaraldehyde, and Tris (hydroxymethylaminomethane) were obtained from Sigma
Chemical Company (St. Louis, MO) and 3-3' diaminobenzidine tetrahydrochloride dihydrate
(DAB) and acetylsalicylic acid (ASA) from Aldrich Chemical Company (Milwaukee, WI).
Solutions
Buffers containing 40 mmol/L divalent manganese, in combination with either 40 mmol/L citrate
or 80 mmol/L acetylsalicylate chelator anions, were prepared as indicated in Table 1. Manganous
salts were tested in the presence of either acetylsalicylate or citrate in preliminary studies. The
greatest amount of reaction product was formed with citrate, which was used in the majority of
experiments. The acetylsalicylate, which can form binary chelates with manganous ions, was
tested to provide a manganous complex with greater lipid solubility and hence greater membrane
penetration. Non-manganese-containing control buffer contained physiologic concentrations of
sodium, potassium, calcium, chloride, and 4 mmol/L Tris-HCl (Table 1). Sodium azide (1
mmol/L) was added, as specified by Briggs et al. [38], to minimize spurious formation of
reaction product by peroxidase [46], catalase [47], and mitochondrial cytochrome oxidase [48].
This concentration of azide does not, however, substantially inhibit copper-zinc or manganese
superoxide dismutases [49]. The pH was adjusted to 7.4 with dropwise addition of 0.5 N NaOH,
with rapid stirring, and the solutions filtered. Buffer solutions were sparged either with 100%
argon gas, to initiate the ischemic/anoxic phase, or with 100% oxygen gas, to accomplish
reoxygenation. To avoid microbubble emboli, flasks of perfusate were bubbled with gas through
a 1/4-inch diameter tube for 30 minutes before the experiment, stoppered, and brought to 37 oC
in a temperature-controlled water bath.
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Diaminobenzidine stock solution was made by dissolving 10 mg DAB-tetrahydrochloride per
milliliter distilled water and slowly adjusting the pH to 5 with dropwise addition of 0.5 N NaOH
(about 2 ml/100 ml) and vigorous stirring to prevent precipitation of DAB by clouds of
concentrated base. If precipitate did form, it was re-dissolved by addition of HCl. An isotonic
working solution of Mn++/DAB buffer, containing 2.5 mmol/L DAB (1 mg/ml) then was
prepared by mixing the 10 mg/ml DAB stock and manganese containing buffer in a ratio of 1:9.
After perfusion of hearts with DAB containing solutions, the collected effluent was detoxified
before disposal by the addition of saturated potassium dichromate solution, as described by
Morrell et al. [50]
Table 1. Solutions

Isolated Heart Preparation
Healthy male Wistar rats weighing approximately 450 g were anesthetized with pentobarbital
sodium (60 mg/kg, intraperitoneally). The chest was opened with heavy scissors, and the sternum
and ventral portions of the ribs were removed to expose the heart and lungs. A #2 silk suture was
placed loosely around the aortic root, and the aorta was incised and cannulated with a blunted
17-gauge needle, excluding air bubbles, such that the tip of the cannula rested 1 to 2 mm above
the aortic valve. The heart was quickly removed and placed in a dish of ice cold 0.9% saline
solution. Myocardial contractions ceased within 5 seconds. The cannula was secured with the
silk suture and mounted on a stopcock. Then the heart was flushed with 30 ml warm, oxygenequilibrated Tris buffered Ringer's solution (without Mn ++ or DAB, Table 1) to clear coronary
circulation of blood.
Ischemia-Reoxygenation Protocol
To initiate the ischemic anoxia, the heart was manually perfused with 15 ml warm (37 oC) argonequilibrated, Tris buffered Ringer's solution that did not contain manganese or DAB. The
measured partial pressure of oxygen (PO2) of argon-equilibrated perfusate solutions, determined
with the aid of a Corning blood gas analyzer, was less than 3 mmHg. The hearts with attached
5

cannulas and stopcocks then were placed in capped 4-oz. specimen jars containing 100 ml
warmed, argon sparged Ringer's solution under argon gas. The jars then were sealed and
transferred to a 37 oC non-shaking water bath for 60 minutes to provide a period of ischemic
anoxia. After the ischemic period, the hearts were removed from the capped, oxygen depleted
jars, and reoxygenation was performed by coronary perfusion through the aortic root with warm,
37 oC to 39 oC, oxygen saturated buffer solutions containing histochemical reagents (Table 1) at
a flow rate of 30 ml/2 min, using a hand-held syringe.
This reperfusion interval was selected in view of earlier studies with electron spin resonance
spectroscopy [34-37], indicating that the maximal formation of an SOD inhibitable free radical
signal occurred during the first 2 minutes of reperfusion. By limiting histochemical perfusion to
this interval, we hoped to maximize the "signal-to-noise ratio" of the method and to minimize
any toxic effects of the manganese on the isolated heart preparation. In the present series of
hearts, the manganese and DAB probes were introduced only at the onset of reoxygenation and
not during the prior ischemic interval. In initial experiments, perfusion pressure was monitored
with a Harvard Apparatus pressure monitor, equipped with a calibrated meter readout and the
flow rate adjusted to maintain 100 mm Hg aortic pressure at the onset of perfusion. This value
proved to be 15 ml/minute, which was then standardized. Staining reactions were stopped and
the tissues fixed by subsequent perfusion, first with 10 ml cold, 0.9% saline, followed by 10 ml
cold Trump's fixative (4% formaldehyde, 1% glutaraldehyde, pH 7.4), each perfusion lasting
approximately 45 seconds. Tissues were stored in vials of chilled Trump's fixative overnight and
prepared for light or electron microscopic examination.
Controls
Control experiments were performed to probe the veracity of the assumed mechanism of reaction
product formation, namely
enzymes

substrates + O2



(O2*)

Mn++



+++

Mn

DAB



histochemical marker,

by interrupting the causal chain of reaction product formation at various steps. These controls
included hearts reoxygenated with plain, non-Mn++/non-DAB buffer solution, non-Mn++
containing DAB solution, non-DAB containing Mn++ solution, and non-oxygen-containing
(argon-sparged) Mn++/DAB solution. Isotonic sodium chloride replaced manganese chloride in
nonmanganese control buffers (Table 1).
Because of previous reports suggesting the calcium dependence of (O2*)  generation by
neutrophils [51] and endothelial cells [52], control hearts perfused with calcium free buffer (both
before ischemia and during reoxygenation) also were studied. The nonischemic control hearts
were prepared in cold saline and then immediately perfused with 30 ml warm, oxygenequilibrated Mn++/DAB buffer.
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Microscopy
Sections of all hearts were processed for light microscopy by dehydration in graded alcohol
solutions, infiltration with xylene, embedding in paraffin wax, sectioning, dewaxing, and
mounting in the usual way. Six-micron thick sections were stained routinely with either
hematoxylin and eosin (H&E) or methyl green. Specimens for transmission electron microscopy
(TEM) were postfixed in osmium, dehydrated in graded ethanol, infiltrated with propylene
oxide, and embedded in Poly/Bed 812 epoxy resin. One micron thick sections were cut and
stained with methylene blue and Azure II.
Areas for thin sectioning were identified by light microscopic examination, and thin sections (5080 nm) were cut with a Reichert Ultracut E ultramicrotome, mounted on copper grids, stained
with uranyl acetate and lead citrate, and examined with a JEOL JEM-100CX transmission
electron microscope. Many earlier experiments had convinced us that the oxidized DAB polymer
is not altered by fixation or subsequent tissue processing for either light or electron microscopy,
making for routine and economical morphologic examination.
Quantitative Morphometry
Vascular profiles of H&E-counterstained slides were examined by light microscopy at 100 X
magnification by an observer who was unaware of the treatment or control group designation of
the specimen. Diaminobenzidine reaction product appeared as amorphous, amber-brown deposits
within blood vessels, which were scored as positive if reaction product was clearly visible and in
contact with the vessel wall. Counts of profiles of positively stained arteries, capillaries, and
veins were made within 800 x 800  2 test areas, delimited by a micrometer eyepiece on the light
microscope. Profiles intersected by the left and upper margins of the counting frame were
included and those intersected by the right and lower margins were excluded to avoid systematic
bias, as previously described [53, 54]. The tissue on each 1 in. x 3 in. glass slide was scanned in
vertical strips at successive 2.5-mm horizontal increments from left to right. Such systematic
sampling with a random start is superior to purely random sampling, because it yields smaller
errors [53].
The mean numerical densities of positively stained arteries, capillaries, and veins per square
centimeter then were tabulated for hearts undergoing the various experimental and control
treatments and compared by a one-way analysis of variance. If a Bartlett's chi-square test for
homogeneity of variance failed, a suitable transformation was found, as described by Anderson
[55], and the analysis of variance was repeated on the transformed data to test the null hypothesis
that the density of stained vessels is the same in hearts from the various experimental and control
groups. Specific comparisons of the effects of experimental versus control treatments were made
using Scheffe multiple comparison tests, which allow comparison of multiple lumped control
groups with one or more experimental groups. The number of observations in each group need
not be the same. (In the case of only two groups, the Scheffe test is mathematically equivalent to
the t-test). A P-value of 0.05 or less was considered significant.
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Results
Histologic sections of perfused, isolated hearts that were studied by light microscopy after
ischemia and reoxygenation with plain buffered Ringer's solution (without manganese or DAB),
fixation in Trump's solution, routine tissue processing, and staining showed completely normal
architecture, except for the absence of formed blood elements. All sections showed good fixation
and the characteristic tinctorial appearance of the counterstain employed.
Light Microscopic Histochemistry
During the first 2 minutes of reperfusion with oxygen equilibrated Mn++/DAB containing
Ringer's solution, the larger coronary arteries of the isolated hearts became noticeably brownish
black in color to the naked eye, indicating reaction product formation that was subsequently
confirmed microscopically. No grossly visible darkening of non-manganese-treated control
hearts was observed.
By light microscopy, the histochemical marker for superoxide production was also readily
visible after routine tissue processing and counterstaining with H&E. The reaction product
appeared in amorphous, amber deposits against the pink background of blood vessel walls.
Counterstaining with methyl green intensified the contrast of the reaction product, rendering it
brown against a green background. The methyl-green-stained sections were most suitable for
black-and-white photomicroscopy (Fig. 1).
The photomicrographs in Figure 1 show selective staining of the luminal surfaces of vascular
endothelium in coronary arterioles and myocardial capillaries and venules in the presence of
manganese and DAB. In many instances, the accumulation of amorphous reaction product was
sufficient to completely (A, bottom) or partially (B, bottom) fill the lumens of smaller capillaries.
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Figure 1. Post-ischemic coronary arterioles and capillaries in an isolated rat heart
subjected to a cycle of60 min ischemic anoxia and 2 min reperfusion with oxygen
sparged, DAB containing Mn++/ASA buffer Methyl green counterstain. Vessels are
shown in transverse section (A) longitudinal section (B). Original magnification 100 X.
Upon light microscopic examination, both arteries and capillaries show deposition of
reaction product on the luminal surfaces of the endothelial carpet (arrows). Completely
or partially filled capillaries are visible in the bottom portions of micrographs (A) and
(B). Black and white photomicrographs were taken using 35 mm Kodak T-max black
and white print film, 1/8 sec exposure. Prints were made on Iford multigrade paper
(Ilford Photo Corp., Paramus, NJ).
The use of citrate as a manganese chelator produced more voluminous amounts of reaction
product, whereas acetylsalicylate chelator appeared to produce somewhat sharper localization to
vascular endothelium at the light microscopic level. The numerical densities of positively stained
vessels per square centimeter obtained with manganese ASA buffer (n = 3), however, were not
significantly different from those obtained with manganese citrate buffer (n = 5). Accordingly
morphometric results from both buffers were pooled for later analysis.
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Generally many more positively stained arteries, veins, and capillaries were formed in the
subepicardium than in the subendocardium. This finding correlated with diminished
subendocardial perfusion after 60 minutes' ischemia in similar post-ischemic rat hearts, which
was readily demonstrated by adding India ink to the perfusate.
Controls
The isotonic substitution of sodium for manganese in DAB containing Ringer's solution almost
completely abolished reaction product formation (Figure 2A). There was virtually no staining of
vascular structures when all aspects of the ischemia/reoxygenation protocol were followed
except for the omission of manganese from the perfusate. This control experiment excludes
simple polymerization of DAB by tissue peroxidases or mitochondrial cytochrome oxidase [48]
as a major mechanism of endothelial reaction product formation. The non-manganese-treated
control also rules out the plausible conclusion that ischemic capillaries take up diaminobenzidine
preferentially, simply by virtue of having been ischemic.
The possibility that Mn ++ might participate in a Fenton-like reaction with endogenous H2O2 was
considered and excluded, because molar concentrations of manganous ions do not react readily
with hydrogen peroxide in vitro, and because addition of 3% hydrogen peroxide to the
Mn++/DAB solution used in the experiments did not produce a visible reaction product. In
contrast, positive control spot tests performed with either ferrous sulfate and hydrogen peroxide
solutions or with granular potassium superoxide and working Mn ++/DAB solutions produced
immediate, dark color reactions.
The elimination of 2 mmol/L Ca ++ from the perfusates (both during anoxia and during
reperfusion) sharply reduced reaction product formation (Figure 2B) with an effectiveness very
nearly equal to the omission of manganese. This finding both suggests specific biochemical
mechanisms and excludes many conceivable artifacts that would not be calcium dependent.
Similarly, there was greatly reduced endothelial staining of nonischemic control tissues perfused
for the same 2-minute period with Mn++/DAB solution, compared with previously ischemic
tissues. This control rules out nonspecific staining simply by virtue of the proximity of the
endothelial cells to high concentrations of perfused staining solutions. Control hearts reperfused
with anoxic, argon-saturated manganese citrate/DAB solution, followed by saline and Trump's
solution, also showed negligible vascular reaction product formation, confirming the strict
oxygen dependence of the phenomenon. Finally when DAB was omitted from the perfusate, no
reaction product could be detected after ischemia and reperfusion.
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Figure 2. No-manganese and no-calcium controls. Sections of a similarly ischemic rat
heart as in Figure 1, reoxygenated with non-manganese (A) or non-calcium (B)
containing DAB buffer. Methyl green counterstain. Details of photomicroscopy similar
to Figure 1. Elimination of manganese from the reperfusion medium (A) abolishes
reaction product formation. This control excludes simple polymerization of DAB by
tissue peroxidases or mitochondrial cytochrome oxidase as a major mechanism of
reaction product formation in these experiments. In particular, if DAB and
endogenous hydrogen peroxide were simultaneously present then peroxidase could
have induced DAB polymerization, as in an ordinary peroxidase stain. The peroxidase
reaction, however, is not manganese dependent. The darkly stained regions of myocytes
in (A) are not reaction product but rather inhomogeneities in the methyl green
counterstain. Elimination of calcium from the perfusate (B) similarly abolishes
reaction product formation in the presence of DAB and manganese. This control
excludes non-biological mechanisms of reaction product formation that would not be
dependent upon calcium ions. Only methyl green counterstaining was observed in this
field.
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Results of light microscopic morphometric analysis of positively stained vascular profiles
(Figure 3) showed that the mean densities of stained vessels in each of the various control groups
were significantly different from those observed in the ischemic and reoxygenated experimental
group. An intense positive reaction using the high manganese/diaminobenzidine method required
the combined presence of divalent manganese, calcium, prior ischemia, and molecular oxygen.

Figure 3. Results of quantitative morphometric analysis of ischemic rat hearts
reperfused with high manganese/diaminobenzidine solutions for 2 min. Vascular
profiles of hematoxylin-eosin counterstained slides were examined by light microscopy
at 100 X magnification and counted in non-overlapping fields. Means values are
plotted. IR = ischemia followed by reoxygenation with 100% oxygen equilibrated buffer
(n = 6). -Mn = IR controls minus manganese (replaced with equimolar sodium
chloride, n = 6). -Ca = IR minus calcium in perfusate (n = 4). NI = non-ischemic
perfusion (n = 4). -Reox = ischemia followed by reperfusion with anoxic, argon
equilibrated perfusate (n = 2). The total number of positively stained vessels (arteries +
capillaries + veins) in the IR group is significantly greater than that in any other group
(P < 0.01 vs. -Mn, -Ca, -Reox; P < 0.05 vs. NI) and significantly greater than that in
the pooled control groups 2 through 5 (P < 0.01).
Note: steriological theory predicts that the measured intersection densities, plotted
here, are exactly one half the length densities (total length per unit volume) of stained
vessels, assuming that they are randomly oriented in space and that they assume all
orientations with equal likelihood. These assumptions would appear approximately
true for all but the largest coronary vessels, which have a trivial influence on the final
results. Both quantities have dimension cm -2.
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Electron Microscopy
The flocculent reaction product associated with the luminal surfaces of endothelial cells was
readily observable in transmission electron micrographs. Figure 4 shows the localization of the
Mn++/DAB reaction product by transmission electron microscopy, after osmium tetroxide
posifixation. The electron-dense reaction product in the vessel lumen corresponds to the
endothelial associated, amber reaction product observed by light microscopy. Reaction product
was always localized to the luminal rather than the anti-luminal surfaces of the endothelial cells,
in many cases appearing in pockets or caveolae on the cell surface (Figure 4B).
Ultrastructural evidence of reaction product formation was not observed in non-manganesetreated control hearts (Figure 5). Interestingly the mitochondrial swelling of the non-manganesetreated heart is more pronounced than in the manganese-treated heart--a phenomenon that
perhaps could be related either to the superoxide dismutase mimetic effect of manganese [40, 56]
or perhaps to its calcium entry blocking effect.

(Please continue on the next page.)

13

Figure 4. Electron micrographs showing reaction product from the high
manganese/diaminobenzidine method in myocardial capillaries. A: Reaction product
appears as a flocculent precipitate within the capillary lumen. Mitochondrial swelling
in this manganese treated heart is less pronounced than in the non-manganese treated
control heart (Figure 5); magnification x 4,400. Bar = 2 µm. B: Reaction product is
associated with the luminal surface only and often appears in small invaginations
(arrow); magnification, x 7,500. Bar = 0.5 µm.
14

Figure 5. Electron micrographs showing absence of reaction product in a nonmanganese treated control heart. There is no reaction product in the capillary lumen,
which was typical, and mitochondrial swelling in the adjacent myocytes is more
pronounced than in Figure 4; magnification, x 4,400. Bar = 2 µm.
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Discussion
The rapid growth of investigative activity in the field of free radicals in biology and medicine has
raised the intriguing possibility that oxygen radicals may constitute a major new class of
pathogens that can be placed in the sequence--bacteria, viruses, auto-antibodies, free radicals--in
order of both decreasing physical size and increasing difficulty of detection. Historically the
understanding of the behavior of newly discovered pathogens has been advanced by microscopic
techniques able to demonstrate their presence in tissue: light microscopy for bacteria, electron
microscopy for viruses, and immunofluorescence for auto-antibodies.
This paper demonstrates the application of a simple microscopic technique to study the
generation of oxygen radicals during early reperfusion of the ischemic isolated rat heart, which
we selected as a model suitable for initial investigation for a number of reasons. The isolated
heart is the classical model of reperfusion injury[10] that is reversible by antioxidant drugs,
given either before [1, 12, 57] or just after [31, 32] the ischemic period; it is a technically
straightforward tissue preparation; and previous studies using ESR spectroscopy have shown
signals indicative of free radical generation in the isolated rat heart during the first few minutes
of reperfusion [34, 37, 58]. Thus we were fairly certain that if free radicals could be
demonstrated histochemically by the high manganese/DAB method, they would be found in the
isolated rat heart.
The results of the high manganese/DAB technique provide clear visual evidence that a burst of
superoxide radicals actually happens during the first 2 minutes of reoxygenation in post-ischemic
rat hearts, in contrast to hearts that have not been subject to ischemic anoxia, or those that have
been rendered ischemic, but not reoxygenated. As suggested by previous studies of pulmonary
artery endothelial cells, both in tissue culture [52, 59] and in situ [43], apparent superoxide
production in the present experiments proved to be calcium dependent. The calcium dependence
of endothelial superoxide production in situ, which we observed, is consistent with an
extracellular to intracellular calcium flux and activation of protein kinase C [60, 61] in a general
scheme similar to excitation-contraction and stimulus-secretion coupling in other types of cells.
The involvement of cyclooxygenase seems unlikely, however, because the activation response in
our studies is preserved in the presence of ASA, a well-known cyclooxygenase inhibitor [62].
The specific localization of initial post-ischemic free radical production to endothelial cells helps
to suggest hypotheses about the pathophysiology of oxygen radical-mediated processes that
would be difficult to formulate from data obtained strictly from bulk myocardium. Early
endothelial superoxide generation may be of special pathophysiologic importance, because a
variety of secondary mechanisms and biochemical cascades including edema, microthrombosis,
the "no-reflow phenomenon" of Ames et al. [63, 64] and leukocyte infiltration [65-69], which
could be readily initiated by endothelial activation. Thus endothelial production of oxygen
radicals may be a key triggering mechanism for the initiation of reperfusion injury in the heart.
This conclusion is consistent with published studies of endothelial cells grown in culture [36, 70,
71], suggesting that endothelial cells, although not "professional phagocytes", can nonetheless
become activated to produce bursts of oxygen radicals.
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The ultrastructural pattern of diaminobenzidine reaction product along the blood-facing sides of
endothelial cells is particularly interesting and worthy of comment. It is possible that superoxide
is only visible in the vascular lumens because superoxide dismutase destroys nascent superoxide
within cells, or because there was limited penetration of manganese and DAB into cells, which
was insufficient to demonstrate superoxide at intracellular sites--especially given the brief, 2minute period of reperfusion. This caveat is especially pertinent to the lack of reaction product
observed in cardiomyocytes in the present study. Strictly speaking, if one sees reaction product
with the high manganese/DAB technique, it suggests that superoxide is being made, but if one
does not see reaction product, it does not mean that superoxide is not being made.
Nevertheless, we suspect that the limitation of superoxide production specifically to the luminal
surface of the endothelium may prove to be quite correct in view of the agreement of our present
results with those of Shlafer and co-workers [72], using a completely independent technique for
histochemical localization of hydrogen peroxide in ischemic and reperfused rabbit hearts. These
investigators found a distribution of cerium reaction product, indicating the presence of H2O2 , on
the luminal surfaces but not the abluminal surfaces of vascular endothelial cells in a pattern that
was virtually identical to the distribution of Mn++/DAB reaction product in the present study.
Formation of the cerium reaction product in Shlafer's study was profoundly inhibited by catalase.
Because either spontaneous or SOD-catalyzed dismutation of superoxide to hydrogen peroxide is
certain to occur, the congruent results provided by the cerium technique and the high
manganese/DAB technique suggest that the same fundamental process is at work.
A biologic rationale for endothelial generation of superoxide also seems apparent. If such a free
radical burst were to function either as a chemoattractant or as a defense against intravascular
invaders, it would be adaptive for radical production to occur only on the blood-facing side of
the cell. Otherwise two undesirable results could occur: damage to the underlying somatic cells,
causing a self-inflicted cardiomyopathy, or damage to the underlying basement membrane,
causing a vascular permeability defect. Accordingly, the polarity of free radical production that
we observed may well be indicative of the normal functional role of the activated endothelial
cell, either in microbial killing or in cell signaling.
Xanthine oxidase, an enzyme that may be present in capillary endothelium [73], has been widely
discussed as a potential source of oxygen radicals in reperfusion injury [14, 25, 28, 30, 74]. Rat
tissues express especially high levels of xanthine oxidase [74-76] compared with tissues of other
species, including humans [77], and it might be argued that the present results could be difficult
to replicate in a low xanthine oxidase species. Interestingly, however, both electron spin
resonance studies [35, 36] and histochemical studies [72] using cerium as a marker for hydro gen
peroxide, have provided evidence for post-ischemic bursts of free radicals in isolated hearts of
the rabbit, a species with very little myocardial xanthine oxidase. Thus, although superoxide
generation and xanthine oxidase activity have been separately localized to capillary endothelium,
the precise biochemical sources of superoxide and the species dependence of the present findings
remain to be determined.
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Conclusions
The high manganese/DAB technique works exceedingly well to disclose sites of superoxide
formation during early reperfusion of the previously ischemic rat heart. The technique allows one
to see the footprints of heretofore putative superoxide radicals, using otherwise routine light and
electron microscopy, to provide direct visual evidence that oxygen radicals are indeed generated
in the initial moments of reperfusion in the perfused rat heart model. The present study was
limited to very early times after the onset of reoxygenation, when electron spin resonance
experiments had shown free radical production to be maximal. These results by no means
exclude superoxide generation by activated leukocytes in subsequent stages of reperfusion
injury. The present study, however, clearly demonstrates the potential role of endothelial cells as
discrete free radical sources in situ, as well as the calcium dependence of endothelial cell
activation.
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